Rest Of Asia Pacific Medical Device Contract Manufacturing Market (2025-2030)
The Rest Of Asia Pacific Medical Device Contract Manufacturing Market was valued at $106.1 Million in 2025 and projected to reach to $178.8 Million by 2030, representing a compound annual growth rate of 11.0%. Rest Of Asia Pacific's medical device contract manufacturing market is positioned for substantial growth, expanding from $106.1 million in 2025 to $178.8 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Medical Device Contract Manufacturing Market Trends and Insights
- Rest Of Asia Pacific represents a critical growth corridor for outsourced medical device production, driven by increasing healthcare demand, rising manufacturing capabilities, and cost-competitive advantages across emerging economies in the region.
- Rest Of Asia Pacific's 11.0% compound annual growth rate reflects strong momentum in contract manufacturing services, including design, prototyping, and full-scale production for medical devices. Rest Of Asia Pacific is attracting significant investment from global medical device manufacturers seeking to diversify supply chains and reduce production costs.
- The region's expanding regulatory frameworks, skilled workforce, and improving infrastructure are positioning Rest Of Asia Pacific as a preferred destination for contract manufacturing partnerships.
- Rest Of Asia Pacific's growth trajectory from 2025 to 2030 underscores the region's strategic importance in the global medical device supply chain and its capacity to support both established and emerging device manufacturers..
Key Market Statistics
- CAGR (2025-2030) 11.0% CAGR
- Market Size, 2025 ~USD 106.1 Million
- Forecast, 2030 ~USD 178.8 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Medical Device Contract Manufacturing Market Overview
Rapid Market Expansion :
Rest Of Asia Pacific's medical device contract manufacturing market is growing at 11% CAGR, outpacing the global average of 10.9%, driven by increasing healthcare infrastructure investments and rising demand for outsourced manufacturing solutions across emerging economies.
Cost Competitiveness :
The region offers significant cost advantages compared to developed markets, attracting multinational medical device manufacturers seeking to optimize production expenses while maintaining quality standards and regulatory compliance.
Healthcare Demand Surge :
Rising healthcare expenditure, aging populations, and increased prevalence of chronic diseases across Rest Of Asia Pacific countries are driving demand for medical devices, creating substantial opportunities for contract manufacturers.
Manufacturing Capability Growth :
Emerging economies in Rest Of Asia Pacific are rapidly developing advanced manufacturing capabilities, including precision engineering, cleanroom facilities, and quality management systems to support complex medical device production.
Rest Of Asia Pacific Medical Device Contract Manufacturing Market Dynamics
- This trajectory reflects the region's increasing attractiveness as a manufacturing hub, supported by improving regulatory frameworks, skilled workforce availability, and strategic investments in healthcare infrastructure.
- The region benefits from proximity to major medical device markets and lower operational costs compared to Western counterparts. Key growth drivers include rising healthcare accessibility initiatives, increasing foreign direct investment in manufacturing facilities, and growing partnerships between local contract manufacturers and global medical device companies.
- As regulatory standards continue to align with international requirements and technological capabilities advance, Rest Of Asia Pacific is expected to capture greater market share in global medical device outsourcing, positioning itself as a critical component of the worldwide supply chain..
Market Ecosystem
MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
End-to-end CDMO for regulated devices leveraging ISO 13485 medical sites and 14 FDA-registered facilities to execute complex injection molding, precision plastics, electronics integration, and automated assembly at global scale. | Accelerates time-to-market with vertically integrated plastics, PCBA, systems build, and digital supply chain that de-risks components across thousands of suppliers and millions of parts, enabling rapid scale-up with compliance built in. |
 |
Contract development and manufacturing for Class II/III devices, instruments, and capital equipment with design engineering and lifecycle services across medical devices, orthopedics, and diagnostics. | Reduces cost and complexity through vertically integrated manufacturing and global execution, supporting complex catheter, RAS, and chronic care products while maintaining a patient-focused quality culture. |
 |
Specialized medical device outsourcing with design-through-manufacture of interventional, cardiovascular, and neuromodulation devices plus batteries and catheters for OEM programs. | Enhances program success through deep domain know-how and vertically integrated capabilities that minimize risk and speed product transfers for high-reliability implantables and minimally invasive platforms. |
 |
Turnkey design, build, and service of complete medical systems including imaging, diagnostics, surgical robotics, and high-volume disposables via ISO 13485 network with FDA-registered sites and NPI facilities worldwide. | Improves reliability and uptime with integrated PCB/PCBA, systems assembly, testing, and global repair/refurbishment, enabling lifecycle support and rapid regional transfers under validated processes. |
 |
Concept-to-market outsourcing with proven FDA Class II/III experience, providing product development, regulatory, manufacturing, and aftermarket services for complex devices across imaging, monitoring, and therapeutics. | Shortens commercialization cycles via full value-stream solutions, robust transition teams, and global compliance to scale efficiently while mitigating supply risks. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Rest Of Asia Pacific's medical device contract manufacturing market will grow from $106.1M (2025) to $178.8M (2030), representing 68.6% total growth over the forecast period.
- Rest Of Asia Pacific maintains an 11.0% CAGR, outpacing global growth and reflecting strong regional demand for outsourced manufacturing services.
- Rest Of Asia Pacific's cost advantages, regulatory improvements, and skilled labor force are driving manufacturer interest in establishing or expanding contract manufacturing operations.
- Rest Of Asia Pacific is becoming a strategic hub for medical device supply chain diversification, supporting both multinational corporations and regional device makers.
Medical Device Contract Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DRUG DELIVERY DEVICES (Device) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10.9% from 2025 to 2030 |
| Largest Segment | DEVICE DEVELOPMENT & MANUFACTURING SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 83.96 (2025) |
| Revenue Forecast (Billions) | ~USD 140.84 (2030) |
| Segments Covered | Device, Type, Device Class, Service |
Rest Of Asia Pacific Medical Device Contract Manufacturing Market Report Segmentation
4 segment dimensions are covered across the global market.
By Device
- Cardiovascular Devices
- Dental Devices
- Diabetes Care Devices
- Diagnostic Imaging Devices
- Drug Delivery Devices
- Endoscopy & Laparoscopy Devices
- Gynecology/ Urology Devices
- Gynecology/Urology Devices
- Ivd Devices
- Neurology Devices
- Ophthalmology Devices
- Orthopedic Devices
- Other Devices
- Patient Assistive Devices
- Patient Monitoring Devices
- Personal Care Devices
- Respiratory Care Devices
- Surgical Devices
By Type
- Autoinjectors
- Cardiovascular Devices
- Dental Devices
- Device & Component Manufacturing Services
- Device Engineering Services
- Diabetes Care Devices
- Diagnostic Imaging Devices
- Drug Delivery Devices
- Endoscopy & Laparoscopy Devices
- Gynecology/Urology Devices
- Infusion Devices & Administration Sets
- Inhalers
- Inspection & Testing Services
- Ivd Consumables
- Ivd Devices
- Ivd Equipment
- Labeling Services
- Neurology Devices
- Ophthalmology Devices
- Orthopedic Devices
- Other Devices
- Other Drug Delivery Devices
- Other Packaging & Assembly Services
- Packaging Validation Services
- Patient Assistive Devices
- Patient Monitoring Devices
- Pen Injectors
- Personal Care Devices
- Primary & Secondary Packaging Services
- Process Development Services
- Respiratory Care Devices
- Sterilization Services
- Surgical Devices
- Syringes
By Device Class
- Class I Medical Devices
- Class Ii Medical Devices
- Class Iii Medical Devices
By Service
- Device Development & Manufacturing Services
- Other Services
- Packaging & Assembly Services
- Quality Management Services
Target Audience
- Medical Device Manufacturers : Global and regional medical device companies seeking to establish or expand contract manufacturing partnerships in Rest Of Asia Pacific to reduce production costs while accessing growing regional healthcare markets.
- Contract Manufacturing Organizations (CMOs) : Existing and emerging CMOs in Rest Of Asia Pacific need market intelligence to benchmark capabilities, identify growth opportunities, and develop competitive strategies within their regional market segment.
- Healthcare Investors & Private Equity : Investment firms evaluating opportunities in Rest Of Asia Pacific's medical device manufacturing sector require detailed market sizing, growth projections, and competitive landscape data for due diligence and portfolio decisions.
- Supply Chain & Procurement Professionals : Corporate procurement teams optimizing global supply chains need Rest Of Asia Pacific-specific data to evaluate sourcing options, negotiate contracts, and manage manufacturing partnerships effectively.
- Market Researchers & Consultants : Industry analysts and consulting firms require granular Rest Of Asia Pacific market data to support client advisory services, competitive analysis, and strategic planning recommendations in medical device manufacturing.
Key Companies in the Rest Of Asia Pacific Medical Device Contract Manufacturing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EIKEN CHEMICAL CO., LTD. | Japan | Public Company | Fecal immunochemical test (FIT) reagents for colorectal cancer screening,Microbiological reagents (media, antimicrobial susceptibility, rapid tests),Urinalysis test strips (occult blood, protein, glucose), |
| CYIENT | India | Public Company | Digital, Engineering & Technology,Design Led Manufacturing,Others (Networks, Operations, and Adjacent Services), |
| JABIL INC. | United States | ||
| FLEX LTD. | Singapore | Public Company | Integrated Technology Solutions (ITS),Regulated Manufacturing Solutions (RMS),Cloud and Power Infrastructure (CPI), |
| PLEXUS CORP. | United States | Public Company | Healthcare/Life Sciences EMS and Design Services,Aerospace/Defense EMS and Engineering,Industrial/Commercial EMS and Sustaining Services, |
| SANMINA CORPORATION | United States | Public Company | Integrated Manufacturing Solutions (design-to-delivery EMS),Components, Products and Services, |
| INTEGER HOLDINGS CORPORATION | United States | Public Company | Cardiac Rhythm Management & Heart Failure (devices, leads, power solutions),Neuromodulation (spinal cord stimulators and related components),Cardio & Vascular / Interventional (cardiology, structural heart, peripheral, neurovascular, oncology), |
| CELESTICA INC. | Canada | Public Company | Connectivity and Cloud Solutions,Advanced Technology Solutions, |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Proprietary Products – stoppers, seals, syringe and cartridge components,Proprietary Products – drug containment systems, self-injection devices, and integrated services,Contract-Manufactured Products – devices and assemblies, |
| RECIPHARM AB | Sweden | Private Company | Advanced Delivery Systems (ADS – inhalation, devices, integrated drug–device),Manufacturing Steriles (MFG-S – injectables, lyophilisation, blow-fill-seal),Manufacturing Solids & Others (MFG-SO – tablets, capsules, semi-solids, liquids, powders), |
| KIMBALL ELECTRONICS, INC. | United States | Public Company | Automotive electronics and assemblies,Medical EMS and contract manufacturing (disposables, drug delivery),Industrial and other electronics manufacturing, |
| NORTECH SYSTEMS, INC. | United States | Public Company | Electromedical devices and imaging assemblies,Electromechanical and industrial systems/box builds,Wire and cable assemblies, |
| CARCLO PLC | United Kingdom | Public Company | In vitro diagnostics and medical consumables,Drug delivery components and assemblies,Aerospace and safety cables and systems, |
EIKEN CHEMICAL CO., LTD.
EIKEN CHEMICAL CO., LTD. is a Japanese public company founded in 1939 with 696 employees. The company operates in the chemical manufacturing sector.
CYIENT
CYIENT is an Indian public company founded in 1991 with 12,049 employees. The company provides engineering, design, and technology services across multiple industries.
JABIL INC.
Insufficient data provided for business description.
FLEX LTD.
FLEX LTD. is a Singapore-based public company founded in 1969 with 149,686 employees. The company is a global electronics manufacturing services provider.
PLEXUS CORP.
PLEXUS CORP. is a United States-based public company founded in 1979 with 20,000 employees. The company provides electronics manufacturing services and specialized solutions.
SANMINA CORPORATION
SANMINA CORPORATION is a United States-based public company founded in 1980 with 35,000 employees. The company is a global provider of electronics manufacturing services and supply chain solutions.
INTEGER HOLDINGS CORPORATION
INTEGER HOLDINGS CORPORATION is a United States-based public company founded in 1970 with 11,000 employees. The company manufactures medical devices and components for the healthcare industry.
CELESTICA INC.
CELESTICA INC. is a Canadian public company founded in 1994 with 23,803 employees. The company provides electronics manufacturing services and supply chain solutions globally.
WEST PHARMACEUTICAL SERVICES, INC.
WEST PHARMACEUTICAL SERVICES, INC. is a United States-based public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for the pharmaceutical and healthcare industries.
RECIPHARM AB
RECIPHARM AB is a Swedish private company founded in 1994 with 6,752 employees. The company provides pharmaceutical manufacturing and development services.
KIMBALL ELECTRONICS, INC.
KIMBALL ELECTRONICS, INC. is a United States-based public company founded in 1961 with 5,700 employees. The company provides electronics manufacturing services and solutions.
NORTECH SYSTEMS, INC.
NORTECH SYSTEMS, INC. is a United States-based public company founded in 1990 with 699 employees. The company provides electronics manufacturing and engineering services.
CARCLO PLC
CARCLO PLC is a United Kingdom-based public company founded in 1924 with 907 employees. The company manufactures precision-engineered components and assemblies for various industries.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Rest Of Asia Pacific ($106.1M in 2025) with 11% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to this high-growth region.
- Competitive Positioning Intelligence : Understand Rest Of Asia Pacific's competitive advantages over other regions, including cost structures, manufacturing capabilities, and regulatory environments, to identify optimal outsourcing and partnership opportunities.
- Regional Market Dynamics : Access detailed insights into country-specific healthcare demand drivers, manufacturing infrastructure development, and regulatory trends unique to Rest Of Asia Pacific that influence contract manufacturing growth.
- Investment & Expansion Strategy : Leverage comprehensive market analysis to develop targeted expansion strategies, facility location decisions, and partnership frameworks specifically tailored to Rest Of Asia Pacific's emerging opportunities and market conditions.
- Supply Chain Optimization : Identify optimal sourcing and manufacturing locations within Rest Of Asia Pacific to reduce costs, improve lead times, and enhance supply chain resilience while maintaining quality and compliance standards.
Frequently asked questions
What is the current market size of medical device contract manufacturing in Rest Of Asia Pacific?
Rest Of Asia Pacific's medical device contract manufacturing market is valued at $106.1 million in 2025 and is expected to grow to $178.8 million by 2030.
What is the projected growth rate for Rest Of Asia Pacific's medical device contract manufacturing market?
Rest Of Asia Pacific's medical device contract manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 11.0% from 2025 to 2030.
Why is Rest Of Asia Pacific becoming a preferred location for medical device contract manufacturing?
Rest Of Asia Pacific offers cost-competitive manufacturing, improving regulatory frameworks, skilled workforce availability, and strategic geographic positioning that attract global medical device manufacturers seeking supply chain diversification.
What services are included in Rest Of Asia Pacific's medical device contract manufacturing market?
Rest Of Asia Pacific's contract manufacturing services encompass design and engineering, prototyping, tooling, full-scale production, quality assurance, and regulatory compliance support for medical devices.
How does Rest Of Asia Pacific's growth compare to the global medical device contract manufacturing market?
Rest Of Asia Pacific's 11.0% CAGR slightly exceeds the global market CAGR of 10.9%, indicating faster regional growth and increasing market share within the global contract manufacturing landscape.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the medical device contract manufacturing market. This approach also helped identify key industry players and enabled classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments from both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers; presidents; CEOs; vice presidents; chairpersons; chief operating officers; chief strategy officers; directors; chief information officers; and chief medical information officers in the medical device contract manufacturing market.
A breakdown of the primary respondents is provided below:
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
Note 1: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
We determined the total size of the medical device contract manufacturing market by triangulating data from three approaches, as described below. After each approach, we calculated a weighted average of the three approaches based on the level of assumptions used in each approach.
Medical Device Contract Manufacturing Market: Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, where applicable, to complete the overall market engineering process and arrive at exact statistics for all segments and subsegments.
Market Definition
The medical device contract manufacturing market refers to the outsourcing of medical device-related activities, including design and development, prototyping, component manufacturing, assembly, testing, packaging, and other value-added manufacturing services, to specialized third-party contract manufacturers by medical device OEMs, pharmaceutical and drug delivery companies, diagnostic companies, and other healthcare companies.
Key Stakeholders
- Medical device OEMs and medtech start-ups
- Pharmaceutical and biotech companies developing combination products
- Medical device contract manufacturers and CDMOs
- Component, raw material, and resin suppliers
- Packaging, labeling, and sterilization service providers
- Testing and validation laboratories
- Hospitals, clinics, and diagnostic laboratories
- Distributors and group purchasing organizations
- Venture capitalists and investors
- Market research and consulting firms
- Government associations
Report Objectives
- To define, describe, and forecast the medical device contract manufacturing market by device type, device class, service, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
-
Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
-
Further breakdown of the Rest of Europe market into Ireland, Switzerland, Poland, Belgium, Austria, and Sweden; the Rest of Asia Pacific market into Singapore, Malaysia, Taiwan, Thailand, Vietnam, and Indonesia; and the Rest of Latin America market into Argentina, Colombia, Chile, and Costa Rica.
Competitive Landscape Assesment
-
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the medical device contract manufacturing market
Get the Full Medical Device Contract Manufacturing Market Report
Full forecast, segment splits, and company analysis for all Medical Device Contract Manufacturing Market.
- China Medical Device Contract Manufacturing Market
- India Medical Device Contract Manufacturing Market
- Japan Medical Device Contract Manufacturing Market
- Malaysia Medical Device Contract Manufacturing Market
- Thailand Medical Device Contract Manufacturing Market
- South Korea Medical Device Contract Manufacturing Market
- Australia Medical Device Contract Manufacturing Market
- Philippines Medical Device Contract Manufacturing Market
- Singapore Medical Device Contract Manufacturing Market
- New Zealand Medical Device Contract Manufacturing Market
- Germany Medical Device Contract Manufacturing Market
- UK Medical Device Contract Manufacturing Market
- France Medical Device Contract Manufacturing Market
- Spain Medical Device Contract Manufacturing Market
- Italy Medical Device Contract Manufacturing Market
- Canada Medical Device Contract Manufacturing Market
- US Medical Device Contract Manufacturing Market
- Brazil Medical Device Contract Manufacturing Market
- Mexico Medical Device Contract Manufacturing Market
- UAE Medical Device Contract Manufacturing Market
- Rest Of Europe Medical Device Contract Manufacturing Market
- Rest Of Latin America Medical Device Contract Manufacturing Market
- Ksa Medical Device Contract Manufacturing Market
- Rest Of GCC Countries Medical Device Contract Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
